Jan Adriaan (Arjan) Haverhals
Chief Executive Officer and President
Mr. Haverhals has served as Milestone Scientific's President since September 2020 and as President and Chief Executive Officer of Milestone Scientific’s Dental Division, Wand Dental Inc., since June 2020. He brings more than 30 years of sales, marketing, product development, and international expansion experience within the medical device, pharmaceutical, and other industries. Prior to joining the Company, Mr. Haverhals was Senior Vice President of Sales at Xcentric Mold & Engineering, where he was instrumental in increasing sales productivity and efficiency for the company's prototype injection molding services, which included leading healthcare company clients. Previously, at Straumann, LLC, a global leader in manufacturing medical and dental devices with over $1 billion in sales, he held a series of senior sales and marketing roles including Vice President of customer marketing & education, where he oversaw all product franchises and led the launch of more than 30 products in the North American market, resulting in double-digit growth. He also served as Senior Vice President for the Nordic Region at Straumann AB, Senior Vice President of Global Sales Digital Solutions, which included oversight of the strategic acquisition of Etkon; and served as Vice President of the Prosthetics Business Unit, where he introduced a new implant and prosthetics product line within a new market segment. He also served as Vice President of Global Marketing & Sales at Elkem AS, one of Norway's largest industrial companies. Previously, Mr. Haverhals served as Executive Vice President of Marketing & Sales at Cresco Ti Systems Sàrl, a global dental implant company, where he was responsible for turning around and managing global sales, marketing, and international business, where he achieved over 100% return on investment for shareholders. Mr. Haverhals holds an MS in Pharmacy from the University of Leyden in the Netherlands.
Chief Financial Officer
Scott Kahn is a seasoned financial leader with over four decades of experience in diverse organizations from Fortune 500 companies to start-ups. Prior to joining Milestone Scientific, Mr. Kahn served as CFO and Vice President at Diopsys since July 2006 where he was responsible for all accounting, finance, human resources and investor relations. Prior to joining Diopsys, Mr. Kahn served as CFO at Diamond Chemical Co., Inc., a privately held chemical manufacturer. Prior to becoming CFO at Diamond Chemical Co. Inc., Mr. Kahn was a Corporate Controller of Pharmaceutical Formulations, Inc., a publicly traded pharmaceutical manufacturer. Previously, Mr. Kahn held various finance, strategy and operational leadership roles. Mr. Kahn received a B.A. in Accounting from Franklin and Marshall College and an M.B.A. in International Business from Rutgers University. He is a Certified Public Accountant licensed in the State of New York.
Dr. Eugene Casagrande
Director of International & Professional Relations
Since 1998, Eugene Casagrande, D.D.S. has served as Director of International and Professional Relations, charged with pursuing a broad range of clinical and industry-related strategic business opportunities for Milestone Scientific. Dr. Eugene R. Casagrande has practiced Cosmetic and Restorative Dentistry for over 30 years in Los Angeles. He is past president of the California State Board of Dentistry and the Los Angeles Dental Society and is a Fellow of the American and International Colleges of Dentists. Dr. Casagrande was a member of the faculty of the University of Southern California, School of Dentistry. He was also the Executive Director of the Los Angeles Oral Health Foundation and the Program Director of the Los Angeles Pediatric Oral Health Access Program. As the Director of International & Professional Relations for Milestone Scientific for over 20 years, he has published multiple articles and has lectured both nationally and internationally at over 100 dental schools and in over 50 countries on Computer-Controlled Local Anesthesia.
Mark Hochman, D.D.S.
Director of Clinical Affairs
Mark Hochman, D.D.S. has served as Milestone Scientific’s Director of Clinical Affairs and Director of Research and Development since 1999. He has a Doctor of Dental Surgery with advanced training in the specialties of Periodontics and Orthodontics from New York University of Dentistry and has been practicing dentistry since 1984. He is a former clinical associate professor at NYU School of Dental Surgery. Recognized as a world authority on Advanced Drug Delivery Instruments, Dr. Hochman has published numerous articles in this area, and shares in the responsibility for inventing much of the technology currently available from Milestone Scientific.